Regenerative potential of Wharton's jelly-derived mesenchymal stem cells: A new horizon of stem cell therapy

J Cell Physiol. 2020 Dec;235(12):9230-9240. doi: 10.1002/jcp.29810. Epub 2020 Jun 18.

Abstract

Umbilical cord Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) have recently gained considerable attention in the field of regenerative medicine. Their high proliferation rate, differentiation ability into various cell lineages, easy collection procedure, immuno-privileged status, nontumorigenic properties along with minor ethical issues make them an ideal approach for tissue repair. Besides, the number of WJ-MSCs in the umbilical cord samples is high as compared to other sources. Because of these properties, WJ-MSCs have rapidly advanced into clinical trials for the treatment of a wide range of disorders. Therefore, this paper summarized the current preclinical and clinical studies performed to investigate the regenerative potential of WJ-MSCs in neural, myocardial, skin, liver, kidney, cartilage, bone, muscle, and other tissue injuries.

Keywords: Wharton's jelly; mesenchymal stem cells; regenerative medicine; umbilical cord.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cell Differentiation / physiology
  • Cell Proliferation / physiology
  • Humans
  • Mesenchymal Stem Cells / cytology*
  • Stem Cell Transplantation* / methods
  • Umbilical Cord / cytology*
  • Wharton Jelly / cytology*